Blackman Samuel C.'s Form 4 filing
Day One Biopharmaceuticals, Inc. (DAWN) · filed Jul 17, 2024
- Accession no.
- 0001415889-24-019681
- Filed
- Jul 17, 2024
- Trade date
- Jul 16, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $320.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blackman Samuel C.CIK 0001863676 | Officer (HEAD OF R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2024 | Common Stock | SSaleDisposed | −20,000 | $16.01 | −$320,200 | 1,121,081 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.